Skip to content

Implementation of CRRT KPI Reports to Standardize and Improve the Quality of CRRT Delivery in Alberta "QUALITY CRRT"

Critical Illness | Acute Kidney Failure

Acute kidney replacement therapy (i.e., dialysis) is used in 6-10% of patients admitted to intensive care units (ICUs). The amount of acute kidney replacement therapy use has increased in Canadian ICUs over the last several years. Continuous renal replacement therapy (CRRT) remains the most common form of acute renal replacement therapy used in ICUs.

Many different parts aspects of CRRT lack a usual way to be done, and because of this, are done differently in different ICUs. Not having generally accepted markers of the performance and delivery of CRRT is a main reason that we have these practice difference. This is an important gap in the way that clinicians deliver this important ICU therapy and is a main focus of ongoing research in ICU and dialysis.

The proposed project is a continuation of a program of work that first reviewed the current state of the quality and safety in ICU and dialysis. Then, a systematic review of all potential quality markers was done to see what options for measures were possible. Next, following a meeting of leaders of dialysis in the ICU, the most important of these measures were ranked to decide which ones could be used in monitoring CRRT for patients.

null

Conditions de participation

  • Sexe:

    ALL
  • Âges admissibles:

    1 and up

Critères de participation

Inclusion Criteria:

* ICU admission
* CRRT initiation

Exclusion Criteria:

- None

Lieu de l'étude

Peter Lougheed Centre
Peter Lougheed Centre
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Royal Alexandra Hospital
Royal Alexandra Hospital
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Red Deer Regional Hospital
Red Deer Regional Hospital
Red Deer, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Foothills Medical Centre
Foothills Medical Centre
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Chinook Regional Hospital
Chinook Regional Hospital
Lethbridge, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Misericordia Community Hospital
Misericordia Community Hospital
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Mazankowski Alberta Heart Institute
Mazankowski Alberta Heart Institute
Edmonton, Albert
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Rockyview General Hospital
Rockyview General Hospital
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Stollery Childrens Hospital
Stollery Childrens Hospital
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Sturgeon Community Hospital
Sturgeon Community Hospital
St. Albert, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Alberta Children's Hospital
Alberta Children's Hospital
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

South Health Campus
South Health Campus
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

University of Alberta Hospital
University of Alberta Hospital
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Grey Nuns Community Hospital
Grey Nuns Community Hospital
Edmonton, Albert
Canada

Contactez l'équipe d'étude

Primary Contact

Oleksa Rewa, MD

Étude parrainée par
University of Alberta
Participants recherchés
Plus d'informations
ID de l'étude: NCT04221932